Microfluidics For Healthcare Application Market Size to grow by USD 110.2 billion between 2024-2028
According to a research report “ Microfluidics For Healthcare Application Market” by Application (In-vitro diagnostics, Pharmaceutical research, Drug delivery services) Material (Polymer-based, Glass-based, Silicon-based) Geography (North America, Europe, APAC, South America, Middle East and Africa)- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 110.2 billion, at a CAGR of 27.16% during the forecast period. Microfluidic devices offer significant advantages in healthcare applications due to their compact size and minimal consumption of reagents. This results in reduced costs and decreased medical waste. With a larger surface-to-volume ratio and low thermal mass, these devices enable precise temperature control, efficient heat transfer, and swift responses to temperature fluctuations. The rapid diffusion of liquids in microfluidic systems enhances assay accuracy and speed. For instance, microfluidics can minimize dispersion broadening in electrophoretic separations through rapid Joule heat dissipation, thereby improving assay performance, decreasing measurement time, and increasing sensitivity..
Browse market data tables, figures, and in-depth TOC on “Microfluidics For Healthcare Application Market” by Application (In-vitro diagnostics, Pharmaceutical research, Drug delivery services) Material (Polymer-based, Glass-based, Silicon-based) Geography (North America, Europe, APAC, South America, Middle East and Africa) Global Forecast to 2028. Download Free Sample
By Application, the In-vitro diagnostics segment is projected to dominate the market size in 2024
Microfluidics plays a pivotal role in the healthcare sector, particularly in in-vitro diagnostics. The technology's significance lies in its use of compact, integrated systems for quick turnaround, resulting in instant results and cost savings. For instance, Abbott Point of Care utilizes over 50,000 i-STAT handheld microfluidic devices for bedside tests. Cepheid's automated microfluidic polymerase chain reaction (PCR) system is another example, enabling rapid screening and diagnosis for Methicillin-resistant staphylococcus aureus (MRSA) infections in hospitals. Microfluidics has revolutionized the diagnostics market, with Point of Care (POC) testing gaining prominence.
By Material, Polymer-based segment is expected to hold the largest market size for the year 2024
In the realm of microfluidics for healthcare applications, polymers serve as the preferred material for fabricating microfluidic devices due to their versatility and cost-effective production. Notable polymers include polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA), and polycarbonate (PC). These polymers offer advantages such as mass production through injection molds and precision machining at a lower cost. PDMS, in particular, is extensively employed for microfluidic chip production and prototyping in research laboratories. Its rapid fabrication process, ease of implementation, and reasonable cost make it a popular choice. Furthermore, PDMS boasts a low elastic modulus (300-500 kPa), which is suitable for manufacturing pumps and valves. Its gas permeability can also be advantageous for transporting carbon dioxide and oxygen in cellular studies.
North America is forecasted to hold the largest market size by region in 2024
The microfluidics market for healthcare applications is experiencing significant growth due to its ability to enhance diagnostic accuracy and efficiency. This technology enables the precise manipulation of fluids at the microscale, facilitating the development of lab-on-a-chip devices. These devices integrate various functions such as sample preparation, detection, and analysis, streamlining workflows and reducing costs. The healthcare industry's increasing demand for point-of-care testing and personalized medicine is further fueling market expansion.
The Microfluidics For Healthcare Application Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Microfluidics, a technology that manipulates fluids at the microscale, has revolutionized various industries, particularly in healthcare applications. The microfluidics market in healthcare is growing rapidly due to its potential in clinical diagnostics, drug delivery systems, and medical research. In clinical diagnostics, microfluidics is used for microdispensing, capillary electrophoresis, and PCR technique for genome analysis, infection detection, and glucose level monitoring. Microfluidic devices made of silicon, glass, and polymers are used for these applications. Soft lithography is a common method for fabricating microfluidic chips. In drug delivery systems, microfluidics is used for insulin pumps and microneedles. The technology also plays a significant role in drug discovery and vascular endothelium studies. The microfluidics market in healthcare is expected to grow significantly due to its potential in improving patient outcomes, reducing costs, and enabling personalized medicine.
Market Research Overview
Microfluidics, a technology that manipulates fluids at the microscale, has revolutionized various industries, particularly Pharmaceutical and Biotechnology in Healthcare. Microfluidics for healthcare applications includes micro dispensing, capillary electrophoresis, and advanced drug delivery systems using polymers, silicon, and glass. These technologies have significant implications for Clinical Diagnostics, enabling high precision PCR, cluster well chips, organs on chip, opto readers, immunoassays, and nanopore technologies. Microfluidics devices are used for Genome analysis, including Fastgene systems, PCR technique, and vascular endothelium studies. Infection detection, glucose levels, and viral load measurement are also possible with microfluidics. Diagnostic laboratories, hospitals, and diagnostic centers benefit from these technologies, which can detect antigens and measure viral load with high accuracy. Microfluidics is also transforming the environment industry with PoC diagnostics, molecular biology, and proteomics. Commercialization of microfluidics-based products includes subcutaneous patches for intelligent medications, insulin pumps, and drug discovery in medical research and life sciences. Soft lithography and microfabrication techniques are used to create these microfluidics devices, expanding their applications and driving the growth of the microfluidics market.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
